Homeobox protein DBX1 (DBX1)

Homeobox protein DBX1 is a transcription factor crucial for the development of specific interneuron populations in the ventral spinal cord, notably the V0 and V1 classes[1][3][7]. DBX1 functions by regulating the transcription factor profile, neurotransmitter phenotype, migratory path, and axonal trajectory of these neurons, distinguishing their fate from adjacent neuronal classes[1][3]. Mutation or absence of DBX1 disrupts normal interneuron specification and has implications for neural development and disorders such as Congenital Central Hypoventilation Syndrome and Epilepsy[3]. DBX1 acts upstream of ventral spinal cord interneuron fate determination but is not considered a direct therapeutic target or receptor for interacting drugs[1][3]. If you seek structured therapeutic or drug interaction information, DBX1 is classified as a transcription factor rather than a classical pharmaceutical target (such as receptor, enzyme, transporter, etc.), and there are currently no known drugs, mechanisms of action, biomarkers, or safety concerns specifically associated with this protein in clinical pharmacology contexts[3][1].

Other names

Developing brain homeobox protein 1HLX1homeobox protein DBX1developing brain homeobox protein 1